Speaker illustration

Doctor Mariana Tinoco

Hospital Senhora da Oliveira - Guimaraes, Guimaraes (Portugal)

Member of:

European Society of Cardiology
Heart Failure Association

The effects of Sacubitril-Valsartan on ICD indication in patients with heart failure with reduced ejection fraction.

Event: Heart Failure 2022

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Heart Failure ePosters - focus on Chronic Heart Failure 7

Thumbnail

Left ventricular reverse remodelling and prognosis of patients treated with SGLT2 inhibitors for heart failure with reduced ejection fraction.

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

Thumbnail

A single center study of patients who suffered cardiac arrest with a presumed diagnosis of acute coronary syndrome.

Event: Heart Failure 2022

Topic: Pathophysiology and Mechanisms

Session: Heart Failure ePosters - focus on CAD / CSS / ACS / ACC

Thumbnail

Sacubitril-Valsartan versus ACEI in left ventricular reverse remodelling and in cardiovascular outcomes.

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

Thumbnail

Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 8

Thumbnail

Predictors of Sacubitril-Valsartan target dose achievement in a real-world population.

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

Thumbnail

Safety and effectiveness of Sacubitril-Valsartan in a real-world population.

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 5

Thumbnail

Left ventricular diastolic function in patients with breast cancer under chemotherapy

Event: ESC Acute CardioVascular Care 2022

Topic: Imaging

Session: e-Posters session

Thumbnail

Comparison of major adverse cardiovascular events between sacubitril-valsartan versus ACEI/ARB therapy in patients with heart failure with reduced ejection fraction

Event: ESC Acute CardioVascular Care 2022

Topic: Epidemiology, Prognosis, Outcome

Session: e-Posters session

Thumbnail

Predictors of major adverse cardiovascular events in patients with heart failure with reduced ejection fraction

Event: ESC Acute CardioVascular Care 2022

Topic: Epidemiology, Prognosis, Outcome

Session: e-Posters session

Thumbnail

This platform is supported by

logo Novo Nordisk